Follow Us on Google DiscoverLeading drug maker GSK posted a revenue of N7.8billion a 12.7% (2013 FY: N6.9billion). Gross profit also increased 8.8% to N2.9billion compared to N2.7billion. Pre-tax was N892million compared to N865million a 3.2% rise.
2014 Q1: GSK Post N892millionPre-tax Profits Continuing In Its Modest Growth
Leading drug maker GSK posted a revenue of N7.8billion a 12.7% (2013 FY: N6.9billion). Gross profit also increased 8.8% to N2.9billion compared to N2.7billion. Pre-tax was N892million compared to N865million a 3.2% rise.
1 min read
